Pfizer Says Its COVID Vaccine Is 90.7% Effective In Kids Ages 5 To 11

The video discusses booster recommendations for COVID-19 vaccines and Pfizer's progress in vaccinating children aged 5 to 11, highlighting the vaccine's 90% efficacy. Dr. Hilary Fairbrother emphasizes the importance of vaccinating children despite their typically mild COVID-19 symptoms, drawing parallels with other pediatric vaccines like chickenpox. The discussion also covers the safety of the vaccine, noting fewer side effects in younger children. Future plans for vaccinating children aged 6 months to 5 years are also mentioned, with expectations for early 2022 approval.

What new insight or understanding did you gain from this video?